It combines two different medicines, dapagliflozin and metformin, into a single daily tablet
This applies to employer-sponsored plans, marketplace plans, and government programs like Medicare and Medicaid
They target multiple disease pathways at once: metabolic dysfunction, cardiovascular disease, inflammation, neurodegeneration, kidney decline, and even some cancers
And, as always, a new drug comes with some caveats and tradeoffs
Triple-Receptor Mechanism: GIP, GLP-1 & Glucagon Retatrutide is a single 39-amino-acid peptide that activates three distinct receptors at once: GLP-1, GIP and glucagon [6][11]
Savings Strategies for GLP-1 Medications Given the high price tag for many brand-name GLP-1 medications, its understandable why patients might seek out more affordable options